Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2012
07/05/2012US20120171242 Modified Antibody
07/05/2012US20120171240 Immunostimulatory compositions and methods
07/05/2012US20120171238 S. aureus allergen
07/05/2012US20120171237 Recombinant chimeric antigens for diagnosis and prevention of scrub typhus
07/05/2012US20120171236 Immunization against chlamydia pneumoniae
07/05/2012US20120171235 Markers of xmrv infection and uses thereof
07/05/2012US20120171229 Synthetic nanocarriers with reactive groups that release biologically active agents
07/05/2012US20120171222 Methods and compositions involving nucleotide repeat disorders
07/05/2012US20120171218 Compositions And Methods For The Therapy And Diagnosis Of Influenza
07/05/2012US20120171214 Polypeptides
07/05/2012US20120171211 Serum resistance factors of gram positive bacteria
07/05/2012US20120171204 Compositions and methods for the treatment and diagnosis of immune disorders
07/05/2012US20120171199 Tricyclic pi3k inhibitor compounds and methods of use
07/05/2012US20120171196 Monoclonal antibodies that neutralize anthrax toxins
07/05/2012US20120171195 Anti-hla-e antibodies, therapeutic immunomodulatory antibodies to human hla-e heavy chain, useful as ivig mimetics and methods of their use
07/05/2012US20120171193 Diagnostic and Treatment Methods for Characterizing Bacterial Microbiota in Skin Conditions
07/05/2012US20120171186 method for producing a nutraceutical composition and the nutraceutical produced by the method
07/05/2012US20120171176 Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
07/05/2012US20120171175 Methods for treating refractory infections in neutropenic individuals
07/05/2012US20120171164 Use of nutritional compositions including lactoferrin in supporting resistance to viral respiratory tract infections
07/05/2012US20120171163 Method for inhibiting a bacterial invasive mechanism using a nutritional composition
07/05/2012US20120171160 Expression of virus entry inhibitors and recombinant aav therefor
07/05/2012US20120171159 Non-pathogenic and/or attenuated bacteria capable of inducing apoptosis in macrophages, process of manufacturing and uses thereof
07/05/2012US20120171158 METHODS OF USING sIP-10, CD26 INHIBITORS AND CXCR3 LEVELS IN A SAMPLE TO ASSESS CLEARANCE OF INFECTION, RESPONSE TO INTERFERON THERAPY, AND TREATING CHRONIC INFECTIONS
07/05/2012US20120171157 Macrocyclic Inhibitors Of Hepatitis C Virus
07/05/2012US20120171129 Inhibition and Dispersion of Bacterial Biofilms with Benzimidazole Derivatives
07/05/2012US20120171122 Loop-Variant Pdz Domains As Biotherapeutics, Diagnostics And Research Reagents
07/05/2012US20120171118 Treatment of meningeal and neural diseases
07/05/2012US20120171116 Arginase Inhibitors and Methods of Use Thereof
07/05/2012DE102011000020A1 Wirkstoff, der Indocyaningrün und/oder Infracyaningrün enthält Contains active substance, the indocyanine green and / or Infracyaningrün
07/05/2012CA2834402A1 Clostridium difficile antigens
07/05/2012CA2823252A1 Plant essential oil-based antimicrobial fish filming compositions and methods of use
07/05/2012CA2823086A1 Plant extracts for the treatment and prevention of infections
07/05/2012CA2822825A1 Bovine viral diarrhea virus type 1b vaccine compositions and methods
07/05/2012CA2822664A1 Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
07/05/2012CA2822556A1 Macrocyclic hepatitis c serine protease inhibitors
07/05/2012CA2822490A1 Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
07/05/2012CA2821859A1 Inactivated poliovaccine
07/05/2012CA2821340A1 Phenanthridine macrocyclic hepatitis c serine protease inhibitors
07/05/2012CA2821111A1 Expression systems
07/05/2012CA2819947A1 Monoclonal antibody recognizing human papillomavirus (hpv) l2 protein and method for measuring hpv-neutralizing antibody titer using the same
07/05/2012CA2754477A1 Method for screening and purifying enterovirus, method for mass-producing enterovirus, and method for manufacturing enterovirus vaccine
07/04/2012EP2471938A2 Recombinant polyvalent vaccine
07/04/2012EP2471937A2 Recombinant polyvalent vaccine
07/04/2012EP2471936A2 Recombinant polyvalent vaccine
07/04/2012EP2471915A1 Modified peptide vaccine derived from influenza m2
07/04/2012EP2471804A1 Diadenosine antibacterial compounds
07/04/2012EP2471783A1 Novel polymorphic form of efavirenz
07/04/2012EP2471781A1 Benzyl aralkyl ether compounds, method for preparing same, intermediate compounds, use of said compounds, method for treatment and/or prevention, pharmaceutical composition and medicament containing same
07/04/2012EP2471553A1 An immunogenic composition comprising peptides derived from cytomegalovirus and the use thereof
07/04/2012EP2471541A1 Medicine for dissolving and eliminating wart and excrescence consisting of protein and its uses
07/04/2012EP2471531A2 Nitro-styrene derivatives having antimicrobial activity
07/04/2012EP2471529A2 Kinase Inhibitors for Preventing or Treating Pathogen Infection and Method of Use Thereof
07/04/2012EP2471527A2 Facially amphiphillc polymers and oligomers and uses thereof
07/04/2012EP2471526A2 Facially amphiphillic polymers and oligomers and uses thereof
07/04/2012EP2471525A2 Facially amphiphllic polymers and oligomers and uses thereof
07/04/2012EP2471524A2 Facially amphiphllic polymers and oligomers and uses thereof
07/04/2012EP2471521A1 Double-layer osmotic pump controlled release tablet of bicyclol and preparation method thereof
07/04/2012EP2471511A1 Liposome formulation suitable for treating or preventing tuberculosis
07/04/2012EP2470564A1 Compositions and methods for treating aspergillosis
07/04/2012EP2470550A1 Bisphosphonates as inhibitors of acid sphingomyelinase
07/04/2012EP2470529A1 A 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivate with substantially undefined crystal shape for preparing said 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative
07/04/2012EP2470500A2 Tetracycline compounds
07/04/2012EP2470195A1 Il-17 for use in treating local infections in mammals
07/04/2012EP2470190A1 Echinocandin derivatives
07/04/2012EP2470189A1 Processes for preparing protease inhibitors of hepatitis c virus
07/04/2012EP2470178A1 Antimycotic pharmaceutical composition
07/04/2012EP2470175A1 Fulvic acid compositions and their use
07/04/2012EP2470171A1 Antimicrobial amino-salicylic acid derivatives
07/04/2012EP2276725B1 New ruthenium complexes as catalysts for metathesis reactions
07/04/2012EP2238142B1 Macrocyclic indoles as hepatitis c virus inhibitors
07/04/2012EP1879654B1 Pharmaceutical combination comprising an antifungal agent and an active substance selected especially from eugenol and carvacrol
07/04/2012EP1863793B1 Hepatitis c virus inhibitors
07/04/2012EP1744781B1 Treatment of infectious diseases
07/04/2012EP1550662B1 Adenine compound and use thereof
07/04/2012EP1487805B1 Pyrimidine derivatives
07/04/2012CN1958608B Method for preparing specificity IgY of anti influenza of birds, and preparation
07/04/2012CN1907293B Combined medicine for treating lpneumonia and preparing process thereof
07/04/2012CN1733798B Hepatitis B virus surface L protein related peptide
07/04/2012CN1536986B Intravaginal drug delivery devices for administration of antimicrobial agent
07/04/2012CN1503796B Polymorphic and other crystalling forms of cis-ftc
07/04/2012CN102549148A Method of preparing plant-derived vlps
07/04/2012CN102548563A 病毒灭活片材 Viral inactivation sheet
07/04/2012CN102548551A Derivatives of N-hydroxybenzamide for treating HIV infections
07/04/2012CN102548419A Leaven-based mixture
07/04/2012CN102533860A Foot and mouth disease vaccine and preparation method thereof
07/04/2012CN102533823A Antiviral preparation with HSV (Herpes Simplex Virus) amplicon as carrier
07/04/2012CN102533798A Recombinant denovirus for expressing foot-and-mouth disease virus type A empty capsid, and application thereof
07/04/2012CN102533797A Preparation method for recombinant coxsackie virus A16 like particle and applications thereof
07/04/2012CN102533787A Peganum harmala lipid transfer protein gene, and recombination expression and application thereof
07/04/2012CN102533772A Anti-HBV (Hepatitis B Virus) decoy aptamer and screening method thereof
07/04/2012CN102533768A siRNA for treating HBV
07/04/2012CN102533767A siRNA for treating HBV
07/04/2012CN102533680A Virus-like particles for pseudorabies virus and preparation method for same
07/04/2012CN102533676A Virus recombinant vaccine A-NDV-LX/14 for newcastle disease and construction method thereof
07/04/2012CN102533675A Recombinant newcastle disease virus LaSota vaccine strain for expressing nipah encephalitis virus F protein
07/04/2012CN102533674A Recombinant duck virus enteritis virus vaccine strain (rDEVul41HA) for expressing avian influenza virus hemagglutinin (HA) genes and construction method as well as application thereof
07/04/2012CN102533673A Chicken infectious bursal disease very virulent cell adapted strain and application thereof
07/04/2012CN102533671A Coxsackie virus A16-type virus strain and applications thereof
07/04/2012CN102533669A Duck byd virus inactivated vaccine and preparation method thereof
1 ... 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 ... 1798